Eliron Amir

Eliron Amir has a diverse and extensive work experience in the field of artificial intelligence and technology. Starting in 2007, they worked at the Israeli Military Intelligence, where they progressed from an Algorithm Developer to an Algorithm Team Leader and eventually became an AI Research Group Leader. During this time, they gained valuable experience in designing and developing algorithms.

In 2014, Eliron joined Body Vision Medical LTD as the Chief Technology Officer (CTO). Eliron held this position until 2017, contributing to the company's technological advancements.

Since 2018, Eliron has been serving as the Chief Product Officer at Nucleai, a leading provider of an AI-powered precision oncology platform. In this role, they are responsible for overseeing the development and implementation of innovative products to improve biomarker discovery and treatment decisions in cancer care. Nucleai works with pharmaceutical companies in licensing its research platform and collaborating in biomarker discovery projects.

Overall, Eliron's work experience demonstrates their expertise in AI, algorithm development, and strategic leadership in the field of technology and healthcare.

Eliron Amir completed a Bachelor of Arts (B.A.) degree in Physics and a Bachelor of Science (BSc) degree in Electrical and Electronics Engineering from Technion - Israel Institute of Technology. Eliron then pursued further education and obtained a Master of Science (MSc) degree in Electrical and Electronics Engineering from the same institution.